Formulations of pimavanserin | Patent Publication Number 20200222381

US 20200222381 A1

Patent NumberUS 10849891 B2

Application Number16836086

Filled DateMar 31, 2020

Priority Date-

Publication DateJul 16, 2020

Original AssigneeAcadia Pharmaceuticals Inc.

Current AssigneeAcadia Pharmaceuticals Inc.

Inventor/ApplicantsEmanuel Joseph Vizzotti
Ravi Tejwani
Stephen Edward Abele

Patent Prosecution report image

Empower your practice with Patexia Publication Prosecution IP Module.

Get access to our exclusive rankings and unlock powerful data.

Check our Latest Report Purchase IP Module

Looking for a Publication Attorney?

Get in touch with our team or create your account to start exploring a network of over 120K attorneys.